Smiles: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSSC[C@@H]8[C@@H](O[C@@H]9[C@H](O)[C@@H](O)[C@H](O%10)[C@@H](CSCCC(O)=O)O9)[C@H](O)[C@@H](O)[C@@H](O[C@H]%11[C@H](O)[C@@H](O)[C@@H](O[C@H]%12[C@H](O)[C@@H](O)[C@@H](O[C@H]%13[C@H](O)[C@@H](O)[C@@H](O[C@@H]%14[C@@H](CSCCC(O)=O)O[C@H](O[C@H]%15[C@H](O)[C@@H](O)[C@@H](O[C@H]%16[C@H](O)[C@@H](O)[C@@H]%10O[C@@H]%16CSCCC(O)=O)O[C@@H]%15CSCCC(O)=O)[C@H](O)[C@H]%14O)O[C@@H]%13CSCCC(O)=O)O[C@@H]%12CSCCC(O)=O)O[C@@H]%11CSCCC(O)=O)O8)O[C@H](O[C@H]%17[C@H](O)[C@@H](O)[C@@H](O[C@H]%18[C@H](O)[C@@H](O)[C@@H]5O[C@@H]%18CSCCC(O)=O)O[C@@H]%17CSCCC(O)=O)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
Inchi: InChI=1S/C31H29N3O2/c1-5-20-7-8-23-26(17-20)32-30-28(23)29(35)24-18-21(6-2)27(19-25(24)31(30,3)4)34-11-9-22(10-12-34)33-13-15-36-16-14-33/h1,7-12,17-19H,6,13-16H2,2-4H3/p+1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.